Question 16346 — pharmacy and medications

Summary

Mr. Hervé Pellois once again draws the attention of the Minister of Solidarity and Health to the situation of child victims of distilbene (DES). After having carefully read the response published in the Official Journal of November 27, 2018 (page 10748) to his written question No. 12059 published in the Official Journal on September 11, 2018 (page 7937), the MP is delighted that the recommendations issued in 2011 by the Agency have been taken into account. French health safety standards for health products, namely annual gynecological monitoring. However, the Minister indicates that “for its part, the HAS has not issued any recommendations in this area, in the absence of recent scientific literature”. This is surprising since recent data was published over a period from 2011 to 2017 reporting two risks for “DES girls”: the increase in the rate of cervical or vaginal dysplasia and the risk of clear cell adenocarcinomas (ACC cancers) of the cervix or vagina with advancing age. In this context, he asks what measures the Government intends to take so that the particular situation of “DES girls” is recognized and that they can benefit from an annual gynecological consultation adapted to their situation and reimbursed 100% by the health insurance system.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.